Reset filters
  • 28 April 2015

Sofosbuvir plus pegylated interferon/ribavirin is highly effective for people with hard-to-treat genotype 3 hepatitis C

Read the article
Graham Foster of Queen Mary's University of London presenting results of the BOSON study. Photo by Liz Highleyman, hivandhepatitis.com
  • 28 April 2015

Sofosbuvir, daclatasvir and ribavirin cures hepatitis C for most people with advanced cirrhosis or liver transplants

Read the article
Fred Poordad of the University of Texas Health Science Center, presenting results of the ALLY-1 study. Photo by Liz Highleyman, hivandhepatitis.com
  • 27 April 2015

New EASL guidelines prioritise interferon-free hepatitis C treatment

Read the article
Jean-Michel Pawlotsky presenting at the International Liver Congress. Photo by Liz Highleyman, hivandhepatitis.com
  • 27 April 2015

Alcohol misuse the strongest predictor of severe liver damage and death in French people with hepatitis C

Read the article
  • 25 April 2015

Expanded vaccination and treatment could help eliminate hepatitis B worldwide

Read the article
  • 25 April 2015

Advanced liver damage is common in people with undiagnosed hepatitis C in US survey

Read the article
  • 25 April 2015

Grazoprevir/elbasvir highly effective in treatment-experienced and HIV-coinfected hepatitis C patients

Read the article
  • 24 April 2015

First HIV home test approved for sale in UK

Read the article
  • 24 April 2015

Many people living with HIV willing to take part in cure research, despite its risks

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.